期刊文献+

山东省耐多药肺结核可疑者筛查情况分析 被引量:19

Respective study on situation of suspects screening of multidrug resistant tuberculosis in Shandong province
下载PDF
导出
摘要 目的回顾性分析山东省全球基金耐多药肺结核防治项目中可疑者筛查情况,探索并完善耐多药肺结核患者的发现策略。方法在项目地区以耐多药肺结核患者的密切接触者、涂片阳性的慢性和复治失败、初治失败、复发、返回及治疗3个月末痰涂片仍阳性的初治涂阳患者等重点人群为主要筛查对象,进行结核菌培养和药敏试验,分析不同人群中耐多药及广泛耐药肺结核的筛出情况。结果开展培养的4318例涂片阳性的耐多药肺结核可疑者中,培养阳性3315例(82.5%);开展药敏试验的3296例可疑者中,422例(14.3%)被诊断为耐多药肺结核,16例(0.5%)被诊断为广泛耐药肺结核,其中复治失败患者中耐多药及广泛耐药肺结核检出率最高,为64.5%,初治失败患者中耐多药及广泛耐药肺结核检出率较高,为41.2%,新患者中耐多药及广泛耐药肺结核检出率较低,仅为6.6%。结论重点人群筛查是一种高效的耐多药肺结核患者的筛查策略,值得在山东省其他地市推广应用。 Objective The paper conducted an analysis on results of suspects screening in areas implementing Shandong Global Fund muhidrug resistant tuberculosis project was to provide reference data for government to control prevalence of multidrug resistant tuberculosis. Methods Chronic and retreatment failure smear positive cases,close contracts of MDR- TB,treatment failure cases,relapse cases,return cases and initial cases that smear positive at the end of three months using drug susceptible test were screened by TB dispensaries,and indexes of confirmed MDR-TB and XDR-TB were calculated and compared between different groups. Results Among of the 4 318 suspects observed,culture positive 3 315 (82.5%);among of 3 296 suspects had done DST,422(14.3%)were confirmed as MDR-TB,16(0.5%)were confirmed as XDR-TB,among of which,MDR-TB or XDR-TB in retreatment failure was highest,that was 64.5%,the rate of MDR-TB or XDR-TB in treatment failure was relatively higher,which was 41.2%. In contrast,the screening rate among new cases was relatively lower,which was 6.6%. Conclusion The screening of high risk populations said above is effective and should be promoted and popularized in Shandong.
出处 《中国医药科学》 2012年第17期121-122,164,共3页 China Medicine And Pharmacy
关键词 耐多药肺结核 重点人群 筛查策略 Multidrug resistant tuberculosis Focus groups Screen strategy
  • 相关文献

参考文献7

二级参考文献32

  • 1Cohn DL, Bustreo F, Raviglione MC, Drug-resistant tuberculosis, review of the worldwide situation and the WHO/IUATLD Global Surveillance Project . International Union Against Tuberculosis and Lung Disease[J]. Clin Infect Dis, 1997,24 (1) :S121--30.
  • 2Anti-tuberculosis drug resistance in the world [J]. The WHO/ IUATLD global project on anti-tuberculosis drug resistance surveillance, 2008.
  • 3Robert J, Trystram D, Truffot-Pernot C, Jarlier V. Multidrugresistant tuberculosis: eight years of surveillance in France [J]. Eur Respir J, 2003,22:833-837.
  • 4Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ. Global incidence of muhidrug-resistant tuberculosis [J]. J Infect Dis,2006,194:479-485.
  • 5Abate G. Drug resistant tuberculosis in Ethiopia: problem scenarios and recommendation [J].Ethiop Med J, 2002, 40: 79-86.
  • 6Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smilh fawzi MC. Drug resislance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR TB in Lima, Peru[J]. Int J Tuherc Lung Dis,2005,9 : 175- 180.
  • 7Augustynowicz Kopec E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M. Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997[J]. Pneumonol Alergol Pol, 2002, 70 : 193 - 202.
  • 8World Health Organization. Global Tuberculosis Control 2008-Surveillance Planning and Financing [J]. Geneva:WHO,2007:6.
  • 9World Health Organization. Global Tuberculosis Control 2008-Surveillance Planning and Financing [J]. Geneva: WHO, 2008 : 4,.
  • 10Centers for Disease Control and Prevention(CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs[J].Ann Pharmacother 2006,40: 1007- 1008.

共引文献88

同被引文献158

引证文献19

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部